The pattern of protein kinase C (PKC) isotype expression in whole extracts of dispersed, freshly isolated adult rat ventricular myocytes and adult rat heart ventricle was examined by immunoblot analysis using antisera specific for PKC-ea, -th, -, -6, -e, -g, or -q isotypes. This analysis revealed significant levels of expression of the Ca2+-independent isotype PKC-e, which was detected as a band of 97-kd molecular mass. PKC-gwas detected principally as a 66-kd band that probably represented a proteolytic product of the holoenzyme. PKC-ng was detected only in whole ventricle as a doublet at 75 and 81 kd and was therefore probably present in nonmyocytic cells. PKC-a, -I31, -y, and -6 could not be detected. Because of our inability to detect PKC-ca, -th, -y, and -6 in whole extracts, PKC isotypes were partially purified from whole heart by DEAE Sepharose chromatography. PKC-a, -f31, -'y, and -6 could still not be detected in the appropriate fractions. All PKC isotypes were detectable in appropriate positive control extracts (brain or certain cultured cell lines). In unstimulated isolated cardiomyocytes, the majority (80-95%) of the PKC-e immunoreactivity was present in the soluble fraction of the extract. On exposure of the cardiomyocytes to 1 ,M phorbol 12-myristate 13-acetate (PMA), PKC-e undergoes a rapid (<30 seconds), sustained (at least 60 minutes), and virtually complete association with the Triton X-100-soluble membrane fraction. There was an associated loss of PKC-e from the soluble fraction. The EC5o for PMA of the translocation event was 15-37 nM. Exposure of cardiomyocytes to 1 ,M 4f3-phorbol 12,13-didecanoate or 1 ,M phorbol 12,13-dibutyrate also resulted in translocation of PKC-e to the membrane fraction, whereas exposure to 1 ,M 4c-phorbol 12,13-didecanoate was without effect. PKC-e also translocated on exposure of cardiomyocytes to 50 jMM epinephrine or 100 nM endothelin-1. However, in both cases, the extent of translocation was significantly less than that after exposure to PMA. We conclude that interventions that lead to hypertrophy of cardiomyocytes (phorbol esters, epinephrine, and endothelin-1) activate
T he activation of the multifunctional Ser-Thr protein kinase, protein kinase C (PKC), has been implicated in the action of a number of hormones and growth factors in a variety of tissues.1-5 In vivo, the major physiological activator of the enzyme is thought to be diacylglycerol (DG), which is formed after the stimulation of membrane phospholipid hydrolysis by agonists. Molecular cloning and biochemical analysis have revealed that PKC exists as a family of at least eight related enzymes that can be further divided into two subfamilies. The first subfamily comprises the a, /, /32, and y isotypes that were originally isolated from the brain. 16, 7 These isotypes are dependent on the presence induce hypertrophy. [17] [18] [19] In the heart, the activation of a number of receptors (including a,-adrenergic,20-24 muscarinic,2025 endothelin,26-28 purinergic,25 and angiotensin II29-31 receptors) stimulates the hydrolysis of membrane phosphoinositides, resulting in rises in DG concentrations. 27, 32 Although the rise in DG concentration should, in turn, lead to activation of PKC in the heart, this has been demonstrated directly only in a few cases. 17, 24, 33, 34 One problem has been that previous studies of cardiac PKC activation have relied largely on measurements of PKC activity with histone III-S as a substrate. 13, 14, 17, 19, 2433 Measurements of this type would reliably detect only PKC-a, -,B, and -_y, and there seems to be little agreement concerning which, if any, of these isotypes are present in the heart.35-39 The expression of Ca2+-independent isotypes in the heart has not been previously examined. Characterization of PKC isotype profiles in cardiac myocytes is of particular interest to us in view of the putative role of the enzyme in cardiac hypertrophy. 40 The characterization of PKC expression in the heart is an essential prelude to understanding its importance in this process. Therefore, we have investigated the expression of PKC in adult rat heart tissue preparations using immunoblotting. Furthermore, we have examined the acute regulation of PKC-E by potentially hypertrophic stimuli: phorbol esters, [17] [18] [19] epinephrine,41,42 and endothelin-1 (ET-1).27,43
Materials and Methods Animals and Materials
Adult male Sprague-Dawley rats were from HarlanOlac, Bicester, UK. All reagents were obtained from Merck, Dagenham, UK, or Sigma, Poole, UK, unless otherwise stated. Aqueous solutions were prepared using double-distilled deionized water. Phorbol esters were dissolved in dimethyl sulfoxide at a concentration of 1 mM. All were stored at -20°C and were diluted to the appropriate concentration with incubation medium (modified Krebs-Henseleit saline containing 25 mM NaHCO3, 4.7 mM KCl, 118.5 mM NaCl, 1 [BSA], 10 mM glucose, and 1 mM added CaCl2 equilibrated with 95% 02-5% C02). Epinephrine was freshly prepared at a concentration of 25 mM in 0.1 mM L-ascorbic acid and subsequently diluted in incubation medium. Collagenase (Worthington type 1) was from Lorne Diagnostics, Twyford, UK. Sodium dodecyl sulfate (SDS) and polyacrylamide gel electrophoresis (PAGE) reagents were from Bio-Rad, Hemel Hempstead, UK. Prestained protein molecular mass standards, horseradish peroxidase-linked donkey anti-rabbit immunoglobulin, horseradish peroxidase-linked sheep antimouse immunoglobulin, the PKC-a//3 monoclonal antibody (MC5), the enhanced chemiluminescence Western blotting detection system, and autoradiography film (Hyperfilm MP) were from Amersham International, Amersham, UK. Nitrocellulose (0.45 ,um BA85, Schleicher & Schuell) was from Anderman & Co., Kingston-UponThames, UK. Peptides corresponding to isotype-specific sequences in the V5 C-terminal regions of PKC species were prepared, and antibodies to these peptides were raised as described previously."4 Briefly, the peptide sequences used (with residue numbers in parentheses) were as follows: PKC-a, PQFVHPILQSAV (661-6726); Partial purification of PKC was carried out essentially as described by Allen and Katz39 and Koide et al. 50 Hearts and brains were rapidly removed from adult male Sprague-Dawley rats. Hearts were perfused briefly with Krebs-Henseleit saline to remove blood. All procedures were then carried out at 4°C. Each tissue was homogenized immediately in ground-glass homogenizers in 4 vol of 20 mM Tris-HCl, 2 mM EGTA, and 2 mM EDTA (pH 7.5) containing 20 ,uM leupeptin, 10 ,uM trans-epoxysuccinyl-L-leucyl-amido (4 -guanidino) -butane (E64), 200 ,uM phenylmethylsulfonyl fluoride (PMSF), 5 mM dithiothreitol, and 1% (vol/vol) Triton X-100. The homogenates were centrifuged for 10 minutes at 10,000g and 2 ml supernatant fraction was then applied to a DEAE Sepharose column (3-mI bed volume) equilibrated with 20 mM Tris-HCl, 2 mM EGTA, and 2 mM EDTA (pH 7.5). The column was washed with 3 ml of the column equilibration buffer containing 20 ,M leupeptin, 10 ,uM E64, 200 ,M PMSF, and 5 mM dithiothreitol and then with 7.5 ml of the same buffer containing 250 mM NaCl (a concentration sufficient to elute all PKC isotypes39,50). The salt wash was retained and concentrated to 0.5 ml by ultrafiltration (Centriprep 10 concentrator, Amicon, Beverly, Mass.). Samples of the total homogenate, Triton X-100 soluble supernatant fraction, and the concentrated PKC-enriched column fractions were taken for protein determination and processing for immunoblotting as described elsewhere in "Materials and Methods."
Subcellular Redistribution of PKC-E in Cardiac Myocytes
Freshly isolated cardiac myocytes (0.7-1 mg myocyte protein per tube, i.e., approximately 140,000-200,000 myocytes per tube) were washed twice and resuspended in incubation medium. After exposure at 37°C to phorbol esters, ET-1, or epinephrine, the myocytes were centrifuged for 3-5 seconds (Eppendorf centrifuge, Merck, Dagenham, UK), and the cell pellet was washed three times in BSA-free incubation medium at room temperature. Two methods were used to disrupt the cells. In the first method (freeze-thaw disruption), the cell pellet was resuspended by vortexing in 0.6 ml ice-cold lysis buffer composed of (mM) Tris-HCl 25, EGTA 5, EDTA 2, and NaF 100 (pH 7.4) containing (gM) leupeptin 20, E64 10, pepstatin A 120, and PMSF 200, along with 5 mM dithiothreitol. Samples were then snap-frozen in liquid N2 and freeze-thawed three times. A sample was taken for estimation of the total cellular PKC-E immunoreactivity before the remaining sample was centrifuged for 10 minutes at 10,OOOg and 4°C. The pellet was further extracted in lysis buffer containing 1% (vol/vol) Triton X-100 for 10 minutes at 4°C and was again centrifuged for 10 minutes at 10,OOOg and 4°C. Boiling SDS-PAGE sample buffer was added to all samples, which were then boiled for a further 5 minutes.
For studies on the effects of epinephrine and ET-1 on the subcellular distribution of PKC-E, a second method (digitonin disruption51) was used. The advantages of this method of cell disruption have been discussed. 51, 52 The cell pellet was resuspended by gentle inversion in 0.6 ml of 0.05% (wt/vol) digitonin in ice-cold lysis buffer and incubated with mixing by inversion at 4°C for 5 minutes. A sample was taken for estimation of total PKC-E before the remaining sample was centrifuged for 2 minutes at 10,00g and 20°C. The membrane fraction was extracted with lysis buffer containing Triton X-100 as above. The resulting fractions were prepared for SDS-PAGE as described above. The data are expressed as mean+SEM of at least three independent observations. Two-tailed Student's t tests for unpaired data were performed, with significance established at p<0.05. Curve fitting to sigmoid curves was carried out using GRAPHPAD software (ISI, San Diego, Calif.). No constants were set in the fitting procedure, and intermediate weighting was used.
Results

Expression of Ca 2`-Dependent PKC Isotypes in Whole Tissue Extracts
The heart is a heterogeneous tissue in terms of cell type, with myocytes constituting only approximately 25% of the cell number (although they constitute approximately 75% of cardiac protein). Thus, to obtain some information concerning the expression of PKC in both myocytic and nonmyocytic cells, we have examined freshly isolated cardiac myocytes and whole heart ventricular samples by immunoblotting with PKC isotypespecific antisera. Extracts of rat brain tissue or transformed cell lines known to overexpress defined PKC isotypes were run simultaneously as positive controls. In the first series of experiments, we attempted to detect Ca2+-dependent isotypes of PKC in cardiac myocytes and whole heart ventricles. Typical results of the immunoblot analysis for the Ca2+-dependent PKC isotypes in brain, cardiac myocyte, and heart samples (50 ,ug total protein in each lane) are shown in Figure 1 . Polyclonal antiserum to PKC-a detected a 79-kd protein in brain, which was effectively competed by the PKC-a peptide that was used as the antigen (Figure la The expression of PKC-8, -e, -4, and -71 in adult rat heart preparations was examined. In agreement with previous studies,475758 PKC-8 was detected as a 74-78-kd protein in brain extracts (100 jg protein loaded) and COS-1 cells overexpressing PKC-8 ( Figure 2a) . Two protein bands of lower molecular mass (44 and 46 kd), which were competed by the PKC-6 peptide antigen, were also detected in COS-1 cells (Figure 2a ). These were presumably catalytic domain fragments of PKC-8 formed during sample processing. 47 No such small molecular mass proteins were present in brain samples. There was no reaction of PKC-6 antiserum with whole heart ventricular or cardiac myocyte samples (100 jg protein loaded).
In brain, cardiac myocytes, and whole heart ventricular samples, PKC-e was detected as a 97-kd protein5059R61 that was competed by PKC-E antigen ( Figure  2b ). The relative abundance of PKC-e in the heart was very much less than in the brain. Although loading of heart protein for SDS-PAGE was 10-fold greater than brain, the subsequent immunoblot showed a much greater abundance of immunoreactivity in brain ( Figure  2b ). This result confirms that PKC-E mRNA detected previously in heart and brain10 is expressed as protein.
PKC-4was detected in brain extracts (100 jig protein loaded) and HeLa cells expressing this isotype as a doublet with a prominent band at approximately 75 kd and a fainter band at 79 kd. Both bands were effectively competed by PKC-4peptide antigen, although the HeLa cell signal was so great that some immunoreactivity remained. It is possible that this doublet might represent different phosphorylation states of PKC-4. In addition, bands of lower molecular mass that were competed by PKC-4 peptide antigen were detected in brain extracts at 67, 64, 56, and 34 kd and in HeLa cell extracts at 64 and 34 kd. The bands of <75-kd molecular mass presumably represent proteolytically produced fragments.48 In contrast to brain and HeLa cell extracts, PKC-4 antiserum reacted only weakly with proteins in samples of cardiac myocytes and heart (100 jg protein loaded). Proteins of 81-, 76-, and 66-kd molecular mass were competed effectively by incubation with PKC-; peptide antigen. The most prominent band was detected at 66 kd, which, because of the effectiveness of the competition reaction, is probably a fragment of the PKC-protein. The molecular mass of PKC-4 was originally reported to be 64 kd. 9 However, more recent studies have provided evidence for an 80-kd PKC-< protein. 48, 6263 The consistency with which PKC-4 fragments with molecular masses of approximately 66 kd are found in the extracts examined here probably reflects the sensitivity of PKC-4 to proteolytic cleavage. 48 Finally, expression of PKC-was examined. In whole heart ventricular extracts, two bands with molecular masses of 81 and 75 kd were detected (50 jg protein loaded), and these were both competed by the PKC-77 antigen peptide (Figure 2d) . No (Figure 3a) or PKC-/1 (Figure 3b ) in spite of being able to establish that this procedure enriched these PKC isotypes in fractions derived from brain. In contrast, PKC-E was readily detected and enriched in heart and brain fractions ( Figure 3c ). For PKC-4, brain fractions showed a weak signal at 75 kd and a strong signal at 57 kd ( Figure  3d ). Heart fractions showed a weak signal at 75 kd and a strong signal at 65 kd (Figure 3d ). These bands probably correspond to the bands at 75 and 56 kd in whole brain supernatant fractions and 76 and 66 kd in whole heart supernatant fractions (see Figure 2c ). For PKC-,81 and PKC-4, the differences in appearance between Figures 1, 2 , and 3 were related to the time of exposure of the film to the immunoblots, which was much shorter in Figure 3 , to demonstrate the effects of partial purification for brain fractions. Longer times of exposure of immunoblots of partially purified PKC did not improve the detectability of PKC-av and PKC-f1 in heart (results not shown). In addition, PKC-y and PKC-6 could not be detected in the heart fractions, but results are not shown because of difficulties with signalto-noise ratio in these immunoblots. In summary, cardiac myocytes express PKC-E and may express PKC-4, although the sensitivity of the latter to proteolysis may present a problem in studies of its regulation in freshly isolated cardiac myocytes or in the heart. Although we could not detect other PKC isotypes using our protocols, we cannot claim to have definitively excluded the possibility that these isotypes are expressed at some level in the adult rat heart.
Regulation of PKC-c
The relatively high level of expression of the holoenzyme form of PKC-e in adult rat cardiac myocytes allows the regulation of this isotype to be studied specifically in physiologically functional freshly isolated cells. We did not attempt to detect the translocation of other PKC isotypes because of the low levels of detectability in our system. The activation of PKC-E was studied using a translocation assay followed by immunoblotting. Ap was chosen specifically to demonstrate the enrichment ofPKC isotypes in brain and heart samples. Longer exposure times did not improve the detection of PKC-a and PKC-f1 in the heart samples. PKC y and PKC-8 remained undetectable in the heart samples (results not shown). The numbers on the right of the figure indicate the positions of the prestained molecular mass standards in kilodaltons. The partial purification protocol was repeated with similar results.
immunoreactive PKC-c is associated with the Triton X-100-soluble cell membrane fraction of freshly isolated cardiac myocytes (results not shown). The remainder is associated with the soluble fraction. Although these findings agree with recent reports that 10-20% of measured PKC activity (histone III-S as substrate) was in the particulate fraction of adult or neonatal cardiac myocytes,19,24 it should be noted that the activity of PKC measured in this way may not be attributable to PKC-E. 10 The tumor-promoting phorbol esters, such as phorbol 12-myristate 13- Figure 5 . The combined results of densitometric analyses of three such experiments are shown in Figure 6 . The data in Figure 6 anti-PKC-e antiserum at a dilution of 1/1,000. Results are tor. 23 Endothelin also stimulates phosphoinositide turnover in these cells.66 Both agents therefore potentially raise DG concentrations and activate PKC. It is possible that the intracellular signaling pathway thus initiated may be important in the development of cardiac hypertrophy (reviewed in Reference 40). Therefore, the activation of PKC-e by these physiological agonists was next examined by either digitonin disruption or freezethawing (Table 2) . Although both methods of disruption gave qualitatively similar results, we observed that translocation of PKC-e as assessed after digitonin disruption was proportionally greater as compared with freeze-thawing. Both epinephrine and ET-1 caused translocation of PKC-e to the membrane fraction after exposure of the myocytes to these agents for 1 minute. However, epinephrine or ET-1 was markedly less effective than PMA. In contrast to PMA (Figure 4 ), the Cardiac myocytes were exposed to the phorbol esters (each at a concentration of 1 gM) for 5 minutes, as described in "Materials and Methods." The concentration of dimethyl sulfoxide carried over into the incubations was 0.1% (vol/vol). Myocytes were subsequently disrupted by freeze-thawing, and the membrane fraction was extracted with Triton X-100, as described in "Materials and Methods." There were three independent observations in each group. Statistical significance of the difference from the control result (taken as 100%) was assessed by an unpaired two-tailed t test.
*p<0.001, tp<0.05, and tp<0.01 vs. control value. Cardiac myocytes were exposed to PMA, endothelin-1, or epinephrine for 1 minute, as described in "Materials and Methods." They were then disrupted by lysis in buffer containing 0.05% (vol/vol) digitonin or by freeze-thawing. The membrane fraction was extracted with Triton X-100, as described in "Materials and Methods." There were four or five independent observations in each group for digitonin disruption. Three of these cell preparations were also analyzed after disruption by freeze-thawing. Sta Discussion The different isotypes constituting the PKC family have been mainly identified by molecular cloning techniques. [6] [7] [8] [9] [10] [11] 57 The availability of cDNA probes has led to the investigation of the tissue distribution of these isotypes by Northern blot analysis,' with the apparent assumption that the relative abundance of the mRNA for a particular PKC isotype provides an indication of the relative abundance of the protein expressed in each tissue. In addition, many studies, including the early studies on the expression of the PKC-a, -,B, and -y isotypes,67 have concentrated on the brain. Mizuno et a157 concluded that the PKC-8 mRNA was ubiquitously expressed in all mouse tissues examined but that expression was significantly less in the heart than in many other tissues (brain, skin, lung, kidney, or intestine). Schaap et al10 reported that mRNA for PKC-E was expressed in a variety of rat tissues, with relative abundance being highest in the brain and next highest in was demonstrated in the brain, kidney, and lung but has not been examined in the heart.9 Most recently, PKC-Gq mRNA expression has been reported in the lung, skin, and whole heart,1",68 and our results ( Figure 2d) (Figure 2b ). It is possible that there is also significant expression of PKC- (Figure 2c) . The other PKC isotypes may be expressed in the cardiac myocyte but are below the levels of detection using our protocols. In addition, there is no certainty that all members of the PKC family have so far been identified. PKC-E has not been knowingly purified from or studied in the heart. This may, in part, result from the use of activity assays with histone substrate during the PKC purification protocols. The model substrate most frequently used (histone III-S) is poorly phosphorylated by PKC-E.5,10 The presence of the Ca'+-independent PKC-E isotype emphasizes the importance of the activation of phospholipid hydrolysis and the production of DG (as opposed to regulation in conjunction with changes in Ca2+ concentrations) in the activation of PKC in the heart.
We were unable to detect PKC-a, -j3k, or -y in extracts of isolated cardiac myocytes or whole heart ventricle ( Figure 1 ). In contrast, Kosaka et al37 have reported the presence of a PKC species containing PKCGa isotype sequence in the rat heart. These researchers first separated PKC activities (histone H, as substrate) by hydroxylapatite chromatography. Most (approximately 90%) of the heart PKC activity eluted as a peak (with a shoulder) at a potassium phosphate concentration of approximately 0.15 M. This species (peak III in the nomenclature used in Reference 37) cross-reacted with an antibody that was raised against residues 4-19 in the V, region of the PKC-a sequence.
A minor peak of activity eluting at 0.09 M potassium phosphate (peak II in the nomenclature used in Reference 37) did not cross-react with antibodies raised against PKC-a, -/3, or -y sequences. The possibility that peak II might contain the Ca'+-independent PKC isotypes PKC-8, -E, or -; (or even the not-then-identified PKC-G) was raised. The presence of the Ca`4-independent isotypes is only clearly demonstrable by an immunological approach or by the use of isotype-specific model substrates (were these available).
In contrast to the results of Kosaka et al,37 a more recent study reported that three peaks of PKC activity (histone III-S as substrate) could be resolved from the soluble fraction of adult rat heart tissue by hydroxylapatite chromatography.36 These eluted at approximately 0.06, 0.10, and 0.13 M potassium phosphate. These were considered to correspond to peak I (the minor peak of activity), peak II (the major peak of activity), and peak III (the intermediate peak of activity) in the nomenclature described in Reference 37. On the basis of their the lung and heart. The expression of PKC-g mRNA elution after hydroxylapatite chromatography and be-cause peaks II and III cross-reacted with monoclonal antibody MC5 (Amersham International), which recognizes a sequence common to PKC-a and PKC-P, peak I was identified as PKC-y, peak II as PKC-f3, and peak III as PKC-a. Our failure to detect any PKC-a, -,B, or -y immunoreactivity in heart or cardiac myocyte samples with the isotype-specific antisera or with the MC5 antibody could suggest a requirement for partial purification and concentration of PKC from these sources before detection is possible. However, as Figure 3 shows, this is not the case. The relatively low abundance of the PKC-a, -,B, and -y isotypes in the heart is also suggested by the finding that the PKC-specific activity in the supernatant fraction of a crude heart homogenate is approximately 5 agrees with the values that we obtained in this study.14 A lesser degree of translocation was also seen on exposure of these cells to high concentrations (10-100 ,uM) of 1,2-dioctanoyl-sn-glycerol.14 Norepinephrine24 or phenylephrine3334 cause small increases in the association of total PKC activity with the cardiac membrane fraction. We are not aware of any direct demonstration of PKC activation by ET-1 in cardiac ventricular myocytes, although this has been demonstrated in smooth muscle preparations.64,75 Phorbol esters, a,-adrenergic agonists, and ET-1 induce responses typical of hypertrophy in adult and neonatal cardiac myocytes. Our general conclusion from the translocation studies is that a common mechanism of action exists for these agents through the activation of a major isotype of PKC in the heart, PKC-E. The finding that epinephrine and ET-1 each induce PKC-E translocation indicates that this PKC isotype may be involved in the coupling of the actions of these agents to the cellular responses in cardiac myocytes.
